GeneralConnection.com ➔ Dictionary
Dictionary Search

mrd

Synonyms

Noun

1. machine readable dictionary

2. MRD, electronic dictionary, lexical database

Usage
Venetoclax Plus Obinutuzumab Improves MRD Negativity Rates Compared With FCR/BR in CLL - Hematology Advisor
Inotuzumab Ozogamicin Shows MRD Clearance in B-Cell ALL Trial - CancerNetwork
ctDNA MRD Status Predicts OS Benefit With Adjuvant Chemotherapy in Resected CRC Liver Metastases - OncLive
Quest Adds Haystack MRD to OncoEMR for Community Oncology - The American Journal of Managed Care® (AJMC®)
Telo Genomics Files Patent to Expand IP Portfolio to Liquid Biopsy MRD Applications for Multiple Myeloma - TMX Newsfile
Bryan Haffer on Signatera’s Expanding Role in MRD-Guided Cancer Care - Oncodaily
ctDNA Assay Precise MRD Expands to Breast, Colorectal, Renal Cancer - Targeted Oncology
Clinical Impact of Next Generation Flow™ MRD in Multiple Myeloma - Labroots
Illumina introduces the first distributed whole-genome sequencing solution for highly sensitive MRD research - Illumina
Venetoclax-Obinutuzumab Boosts MRD Clearance in CLL - Medscape
With MRD-Driven Accelerated Approvals, Efficacious Multiple Myeloma Drugs Are Reaching Patients More Quickly and Providing Functional Cures Sooner - ASCO Daily News
MRD Testing Across CLL Treatment Strategies - CancerNetwork
Experts Outline the Evolving Role of ctDNA-Based MRD Testing Across Solid Tumors - OncLive
Tec-Dara Shows MRD-Negative, PFS Benefit in High-Risk Myeloma, but Longer Follow-Up Needed: Rahul Banerjee, MD - The American Journal of Managed Care® (AJMC®)
MRD Test Predicts Chemotherapy Survival Benefit in Colorectal Liver Metastases - CancerNetwork
Belantamab Mafodotin Yields Sustained MRD Negativity in R/R Myeloma - OncLive
NCCN Updates Bladder Cancer Guidelines for ctDNA MRD Testing - CancerNetwork
Foundations of ctDNA and MRD Testing - OncLive
CEPHEUS Trial and MRD Outcomes in Newly Diagnosed Multiple Myeloma - CancerNetwork
AI and MRD Take Center Stage on Day 2 of ASCO Breakthrough 2026 - CancerNetwork
NCCN Guidelines Recommend ctDNA-MRD Testing in MIBC Care - Targeted Oncology
Isa-VRd Sustains and Deepens MRD Negativity in Transplant-Ineligible Myeloma - Targeted Oncology
MRD Testing Falls Short as Reliable Survival Surrogate in CLL - Hematology Advisor
NCCN Includes PCR ctDNA-MRD Testing in MIBC Treatment Algorithm - OncLive
Natera’s Signatera receives EU IVDR certification for MRD testing - Investing.com
Myriad Genetics Expands Minimal Residual Disease Testing for Three Cancer Types - Clinical Lab Products
Ultima Genomics releases groundbreaking TRACERx MRD data showing ppmSeq performance and unveils clinical progress of whole genome sequencing at inaugural global MRD Symposium at AACR 2026 - PR Newswire
Is MRD Testing to Guide Cancer Treatment Ready for Prime Time? - ASCO Daily News
MRD-Based End Point Set to Surge Under FDA Guidance in Multiple Myeloma - OncLive
Minimal Residual Disease Testing in Multiple Myeloma - ASCO Daily News
Why MRD Negativity is the Modern Goal in Myeloma Treatment - Cure Today
Why Natera (NTRA) Is Up 6.7% After Japan Approves First MRD Test for Colorectal Cancer - Yahoo Finance
Allogeneic CAR T Cema-Cel Boosts MRD Clearance in LBCL - Targeted Oncology
Quest Diagnostics Receives New York State Approval for Haystack MRD®, Broadening Patient Access to ctDNA Minimal Residual Disease Testing - PR Newswire
NCCN Recommends ctDNA-MRD Testing Using Signatera™ Technology in Landmark Bladder Cancer Guideline Update - BioSpace
Role of ASCT, Transplant, and MRD Are Examined in NDMM - Targeted Oncology
In Vivo CAR T-Cell Therapy Drives Responses and MRD Negativity in R/R Myeloma - OncLive
Ultrasensitive ctDNA-MRD Validated Following First-Line Therapy in LBCL - Hematology Advisor
Illumina Announces MRD Kit Ahead of ASCO Meeting - Genetic Engineering and Biotechnology News
Natera's Moshkevich Discusses TOMR Approach and the Future of MRD-Guided Care - The American Journal of Managed Care® (AJMC®)
Exact Sciences Broadens Evidence for Oncodetect MRD Test in Early Triple-Negative Breast Cancer - 360Dx
MRD Negativity Following Liso-Cel Linked to Longer PFS in R/R Follicular Lymphoma - Cancer Therapy Advisor
Navigating FDA Expectations for MRD in Multiple Myeloma - IQVIA
Examining BelaDRd, BCMA Targeting, and Contextualizing Early MRD Data - The American Journal of Managed Care® (AJMC®)
Dor Abelman, BS, on Multiple Myeloma: cfDNA WGS vs Plasma Proteomics for Minimally Invasive MRD Assessment - The ASCO Post
MRD-Guided Azacitidine Delays Relapse in MDS and AML - Hematology Advisor
Natera demonstrates MRD test benefit in colorectal cancer patients - Medical Device Network
FDA Releases Draft Guidance for Use of MRD and CR as Primary Endpoints in Multiple Myeloma Trials - The ASCO Post
FDA Approves Adjuvant Atezolizumab for ctDNA MRD–Positive MIBC - Targeted Oncology
Signatera™ MRD Test Predicted Overall Survival Benefit from Chemotherapy in Resected Metastatic Colorectal Cancer - Yahoo Finance
MRD End Point Brings “Positive Change” to Multiple Myeloma Research - CancerNetwork
MRD Moves to Center Stage in Multiple Myeloma: Nicholas Richardson, DO, MPH - The American Journal of Managed Care® (AJMC®)
Natera’s Solomon Moshkevich on how MRD testing pinpoints cancer recurrence - MedTech Dive
FDA Approves Atezolizumab for Adjuvant Treatment of MRD-Positive Muscle-Invasive Bladder Cancer - The ASCO Post
FDA Issues Draft Guidance on MRD and CR End Points in Multiple Myeloma - Targeted Oncology
Quest Gains New York Approval for Haystack MRD Cancer Monitoring Test - Clinical Lab Products
Foundation Medicine Launches MRD Test Combining Structural Variants and Digital PCR - Clinical Lab Products
Validation of a methylation-based, tissue-free MRD assay in colorectal cancer patients from the GALAXY study - Nature
KLN-1010 In Vivo CAR Achieves 100% MRD Negativity in R/R Myeloma - Targeted Oncology
Ultra-high-sensitivity next-generation sequencing–based MRD predicts outcome in intensively treated older patients with acute myeloid leukemia: results from the ALFA-1200 cohort - Nature
MRD-Guided CLL Treatment Duration: Personalization or Malpractice? - The American Journal of Managed Care® (AJMC®)
The Future of MRD in Breast Cancer Treatment - Targeted Oncology
Peri-transplant TP53 molecular MRD as a prognostic biomarker of relapse in TP53 -mutated AML/MDS undergoing allogeneic HCT - Nature
Myriad Genetics Expands Availability of Precise MRD™ for Colorectal, Renal and Breast Cancers, Supported by New Publication - Yahoo Finance
City of Hope to Evaluate Quest Diagnostics' Haystack MRD® for Guiding Patient Management in Multiple Cancers - PR Newswire
From Trial Data to Clinical Practice: DVRd, MRD Testing, and Payer Coverage Considerations in NDMM - The American Journal of Managed Care® (AJMC®)
Isatuximab Regimen Improves MRD Negativity in Transplant-Eligible NDMM - CancerNetwork
MRD Is Now the Endpoint That Matters: The EMN24 IsKia Trial Just Proved It - The Clinical Trial Vanguard
DGX's Stock Rises on Haystack MRD Test's Approval From NYSDOH - Yahoo Finance
Sustained MRD Negativity Predicts Long-Term Outcomes in Multiple Myeloma - HMP Global Learning Network
MRD Testing in Blood Cancer: Aiming to Improve Treatment Strategies - AstraZeneca
MRD as a Development Strategy: The Paradigm Shift Reshaping Oncology Trial Design - Syneos Health
utDNA–guided MRD assessment may predict response to BCG in NMIBC - Urology Times
CAR T Achieves 100% MRD Negativity in Newly Diagnosed Multiple Myeloma - Targeted Oncology
Quest Diagnostics’ Haystack MRD test secures NYSDOH approval - Medical Device Network
Labcorp Expands MRD Testing for Breast, Lung and Colon Cancer Recurrence Risk - PR Newswire
FDA outlines draft policy on MRD, complete response for accelerated approvals in multiple myeloma - Fierce Biotech
ASCO26: Abbott demonstrates MRD test benefit in TNBC recurrence - Medical Device Network
MRD as a Breakthrough Regulatory End Point in the EXCALIBER-RRMM Trial - Targeted Oncology
Sonrotoclax Plus Zanubrutinib Yields High Undetectable MRD Rates in Treatment-Naive CLL/SLL - OncLive
Cilta-Cel Yields 100% MRD Negativity in High-Risk Smoldering Myeloma - Targeted Oncology
Single-Cell MRD Assessment in AML: Advancing Beyond Standard Care - the-scientist.com
New MRD data may help identify recurrence risk in triple-negative breast cancer - STAT
MRD as a Therapeutic Compass: Pharmacists at the Helm of Adaptive Oncology - Pharmacy Times
Natera’s MRD test predicts survival benefit after colorectal liver surgery - MSN
Signatera™ MRD Test Predicted Overall Survival Benefit from Chemotherapy in Resected Metastatic Colorectal Cancer - The Norfolk Daily News
Hidden metastases reveal clues to colorectal cancer recurrence - Medical Xpress
Foundation Medicine buying Saga Dx and its MRD test for $595M - BioWorld News
Time-Limited Zanubrutinib Plus Venetoclax: MRD-Guided Outcomes from SEQUOIA Arm D - CancerNetwork
AACR 2026: 100% MRD-negativity rate achieved for high-risk smoldering multiple myeloma - Oncology Central
ctDNA Assays Advance Breast Cancer MRD Detection, Prompt Critical Application Questions - OncLive
Beyond the NGS panel: Advancing precision oncology through WGS, Methylomics, and MRD Integration - Labroots
Sonrotoclax Plus Zanubrutinib Achieves Undetectable MRD Rates Above 90% in Frontline CLL/SLL - Pharmacy Times
Noninvasive Blood Test Launched for Myeloma MRD Monitoring - Cure Today
NTRA's Signatera Secures PMDA Approval for MRD Testing in CRC in Japan - Yahoo Finance
Consolidation With Cema-Cel Shows Favorable Safety in MRD-Positive DLBCL - Targeted Oncology
What MRD Testing Can Mean for Patients With Breast Cancer and Survivors - Cure Today
Roche builds MRD testing arsenal in $595m Saga Diagnostics buyout - Medical Device Network
Azacitidine Triplet Produces Durable MRD-Negative Remissions in IDH1+ AML - CancerNetwork
Whole-Genome Sequencing-Based MRD Detection Under Study in Resectable Renal Cell Carcinoma - Taigo Kato - UroToday
Foreign Language Equivalents
Foreign Language Equivalents of 'mrd'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
mrf,   mr,   mrdd,   mdr,   mtd,   rmd,   mrs,   rd,   md,   nrd,   ,rd,   mmrd,   med,   mrrd
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z